Two Firsts For Keytruda As NICE Says Yes To English Funding For Advanced Cervical Cancer
Executive Summary
Keytruda is the first new cervical cancer treatment to be appraised by the health technology assessment institute, NICE, in nearly 15 years, says MSD.